Comparative genomic hybridization study of arsenic-exposed and non-arsenic-exposed urinary transitional cell carcinoma

Toxicology and Applied Pharmacology

Volumn 227, Issue 2, 2008, Pages 229-238

  Hsu, Ling I ^a   Chiu, Allen W ^b   Pu, Yeong Shiau ^c   Wang, Yuan Hung ^d   Huan, Steven K ^e   Hsiao, Cheng Hsiang ^c   Hsieh, Fang I ^d   Chen, Chien Jen ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Arsenic; Comparative genomic hybridization; p53 immunohistochemistry; Urinary transitional cell carcinoma

Indexed keywords

ARSENIC; PROTEIN P53;

ARTICLE; CANCER CELL; CANCER STAGING; CARCINOGENESIS; CHROMOSOME 17P; CHROMOSOME 1P; CHROMOSOME 4P; CHROMOSOME 4Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CIGARETTE SMOKING; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; EXPOSURE; GENE FREQUENCY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; TRANSITIONAL CELL CARCINOMA;

ADULT; ARSENIC; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; DNA; FEMALE; GENE DOSAGE; GENES, P53; HUMANS; HYBRIDIZATION, GENETIC; IMMUNOHISTOCHEMISTRY; MALE; POISONS; REGRESSION ANALYSIS; SMOKING; TAIWAN; URINARY BLADDER NEOPLASMS; WATER SUPPLY;

EID: 39149104017     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.10.024     Document Type: Article

References (55)

1. Aboulkassim T.O., LaRue H., Lemieux P., Rousseau F., and Fradet Y. Alteration of the PATCHED locus in superficial bladder cancer. Oncogene 22 (2003) 2967-2971
2. Bruch J., Wohr G., Hautmann R., Mattfeldt T., Bruderlein S., Moller P., Sauter S., Hameister H., Vogel W., and Paiss T. Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q. Genes, Chromosomes Cancer 23 (1998) 167-174
3. Chen C.J., Chuang Y.C., Lin T.M., and Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 45 (1985) 5895-5899
4. Chien C.W., Chiang M.C., Ho I.C., and Lee T.C. Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice. Environ. Health Perspect. 112 (2004) 1704-1710
5. Chiou H.Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., Lin J.S., Huang C.H., and C.J.C. Incidence of internal cancers and ingested inorganic arsenic. A seven-year follow-up study in Taiwan. Cancer Res. 55 (1995) 1296-1300
6. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., and Chen C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 153 (2001) 411-418
7. Dulout F.N., Grillo C.A., Seoane A.I., Maderna C.R., Nilsson R., Vahter M., Darroudi F., and Natarajan A.T. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from Northwestern Argentina exposed to arsenic in drinking water. Mutat. Res., Genet. Toxicol. 370 (1996) 151-158
8. El-Rifai W., Kamel D., Larramendy M.L., Shoman S., Gad Y., Baithun S., El-Awady M., Eissa S., Khaled H., Soloneski S., Sheaff M., and Knuutila S. DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer. Am. J. Pathol. 156 (2000) 871-878
9. Esuvaranathan K., Chiong E., Thamboo T.P., Chan Y.H., Kamaraj R., Mahendran R., and Teh M. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha. Cancer 109 (2007) 1097-1105
10. Habuchi T., Luscombe N., Elder P.A., and Knowles M.A. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics 48 (1998) 277-288
11. HopenhaynRich C. Bladder cancer mortality associated with arsenic in drinking water in Argentina (vol 7, pg 117, 1996). Epidemiology 8 (1997) 334-334
12. Hornigold N., Devlin J., Davies A.M., Aveyard J.S., Habuchi T., and Knowles M.A. Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene 18 (1999) 2657-2661
13. Hsu, L.I. (2001). Epidemiologic studies on urinary transitional cell carcinoma among residents in the blackfoot disease-endemic area in Taiwan. Doctoral thesis, National Taiwan University.
14. Huang S.C., and Lee T.C. Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis 19 (1998) 889-896
15. International Agency for Research on Cancer. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs (1987) 1-42
16. Jha A.N., Noditi M., Nilsson R., and Natarajan A.T. Genotoxic effects of sodium arsenite on human cells. Mutat. Res. 284 (1992) 215-221
17. Kallioniemi A., Kallioniemi O.P., Citro G., Sauter G., Devries S., Kerschmann R., Caroll P., and Waldman F. Identification of gains and losses of DNA-sequences in primary bladder-cancer by comparative genomic hybridization. Genes, Chromosomes Cancer 12 (1995) 213-219
18. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., and Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 (1992) 818-821
19. Knowles M.A., Elder P.A., Williamson M., Cairns J.P., Shaw M.E., and Law M.G. Allelotype of human bladder-cancer. Cancer Res. 54 (1994) 531-538
20. Koo S.H., Kwon K.C., Ihm C.H., Jeon Y.M., Park J.W., and Sul C.K. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet. Cytogenet. 110 (1999) 87-93
21. Kuo T.L. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Report Inst. Pathol. Natl. Taiwan Univ. 20 (1964) 7-13
22. Lee T.C., Huang R.Y., and Jan K.Y. Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat. Res. 148 (1985) 83-89
23. Lee T.C., Oshimura M., and Barrett J.C. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture. Carcinogenesis 6 (1985) 1421-1426
24. Lee T.C., Lee K.C., Tzeng Y.J., Huang R.Y., and Jan K.Y. Sodium arsenite potentiates the clastogenicity and mutagenicity of DNA crosslinking agents. Environ. Mutagen. 8 (1986) 119-128
25. Lee T.C., Tanaka N., Lamb P.W., Gilmer T.M., and Barrett J.C. Induction of gene amplification by arsenic. Science 241 (1988) 79-81
26. Lerda D. Sister-chromatid exchange (Sce) among individuals chronically exposed to arsenic in drinking-water. Mutat. Res. 312 (1994) 111-120
27. Liu L., Trimarchi J.R., Navarro P., Blasco M.A., and Keefe D.L. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J. Biol. Chem. 278 (2003) 31998-32004
28. Lo M.C., Hsen Y.C., and Lin B.K. The Second Report on the Investigation of Arsenic Content in Underground Water in Taiwan Province. In: Sanitation T.P.I.o.E. (Ed) (1977), Provincial Institute of Environmental Sanitation, Taichung
29. Lofroth G., and Ames B.N. Mutagenicity of inorganic-compounds in Salmonella-Typhimurium-Arsenic, chromium and selenium. Mutat. Res. 53 (1978) 65-66
30. Mahdy E., Yoshihiro S., Zech L., Wester K., Pan Y., Busch C., Dohner H., Kallioniemi O., Bergerheim U., and Malmstrom P.U. Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer. Anticancer Res. 19 (1999) 7-12
31. Mass M.J., and Wang L.J. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res., Rev. Mutat. Res. 386 (1997) 263-277
32. Moore L.E., Smith A.H., Eng C., DeVries S., Kalman D., Bhargava V., Chew K., Ferreccio C., Rey O.A., Hopenhayn C., Biggs M.L., Bates M.N., and Waldman F.M. P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Carcinogenesis 24 (2003) 1785-1791
33. Moore L.E., Smith A.H., Eng C., Kalman D., DeVries S., Bhargava V., Chew K., Moore D., Ferreccio C., Rey O.A., and Waldman F.M. Arsenic-related chromosomal alterations in bladder cancer. J. Natl. Cancer Inst. 94 (2002) 1688-1696
34. Moore L.E., Smith A.H., HopenhaynRich C., Biggs M.L., Kalman D.A., and Smith M.T. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol. Biomark. Prev. 6 (1997) 31-36
35. Ramirez P., Eastmond D.A., Laclette J.P., and OstroskyWegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res., Rev. Mutat. Res. 386 (1997) 291-298
36. Reznikoff C.A., Belair C.D., Yeager T.R., Savelieva E., Blelloch R.H., Puthenveettil J.A., and Cuthill S. A molecular genetic model of human bladder cancer pathogenesis. Semin. Oncol. 23 (1996) 571-584
37. Richter J., Beffa L., Wagner U., Schraml P., Gasser T.C., Moch H., Mihatsch M.J., and Sauter G. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am. J. Pathol. 153 (1998) 1615-1621
38. Richter J., Jiang F., Gorog J.P., Sartorius G., Egenter C., Gasser T.C., Moch H., Mihatsch M.J., and Sauter G. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res. 57 (1997) 2860-2864
39. Rossman T.G., Stone D., Molina M., and Troll W. Absence of arsenite mutagenicity in E. coli and Chinese hamster cells. Environ. Mutagen. 2 (1980) 371-379
40. Sandberg A.A., and Berger C.S. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J. Urol. 151 (1994) 545-560
41. Sauter G. Rudolf Virchow Prize 1997. Molecular cytogenetic analysis of superficial urothelial cancer of the bladder. Verh. Dtsch. Ges. Pathol. 81 (1997) 18-27
42. Sauter G., Moch H., Carroll P., Kerschmann R., Mihatsch M.J., and Waldman F.M. Chromosome-9 loss detected by fluorescence in-situ hybridization in bladder-cancer. Int. J. Cancer 64 (1995) 99-103
43. Sciandrello G., Caradonna F., Mauro M., and Barbata G. Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis 25 (2004) 413-417
44. Simon R., Burger H., Brinkschmidt C., Bocker W., Hertle L., and Terpe H.J. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J. Pathol. 185 (1998) 345-351
45. Smith A.H., Goycolea M., Haque R., and Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147 (1998) 660-669
46. Union International Contre Le Cancer. Union International Contre Le Cancer: TNM Classification of Malignant Tumors (1978), Union International Contre Le Cancer, Geneva
47. Vanni R., Scarpa R.M., Nieddu M., and Usai E. Cytogenetic investigation on 30 bladder carcinomas. Cancer Genet. Cytogenet. 30 (1988) 35-42
48. Vega L., Gonsebatt M.E., and Ostroskywegman P. Aneugenic effect of sodium arsenite on human-lymphocytes in-vitro-an individual susceptibility effect detected. Mutat. Res., Sect. Environ. Mutagen. Relat. Subj. 334 (1995) 365-373
49. Voorter C., Joos S., Bringuier P.P., Vallinga M., Poddighe P., Schalken J., Dumanoir S., Ramaekers F., Lichter P., and Hopman A. Detection of chromosomal imbalances in transitional-cell carcinoma of the bladder by comparative genomic hybridization. Am. J. Pathol. 146 (1995) 1341-1354
50. Waldman F.M., Carroll P.R., Kerschmann R., Cohen M.B., Field F.G., and Mayall B.H. Centromeric copy number of chromosome-7 is strongly correlated with tumor grade and labeling index in human bladder-cancer. Cancer Res. 51 (1991) 3807-3813
51. Williamson M.P., Elder P.A., Shaw M.E., Devlin J., and Knowles M.A. P16 (Cdkn2) is a major deletion target at 9p21 in bladder-cancer. Hum. Mol. Genet. 4 (1995) 1569-1577
52. World Health Organization. World Health Organization: histological typing of urinary bladder tumours. International Classification of Tumors vol. 10 (1973), World Health Organization, Geneva
53. World Health Organization. World Health Organization: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemical to Humans: Some Metal and Metallic Compounds (1980), International Agency for Research on Cancer, Lyon
54. Yamanaka K., and Okada S. Induction of lung-specific DNA-damage by metabolically methylated arsenics via the production of free-radicals. Environ. Health Perspect. 102 (1994) 37-40
55. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., and Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10907-10912